OCT 19, 2016 8:38 PM PDT

New Anti-inflammatory Drugs Also Treat Depression

WRITTEN BY: Kara Marker
A new class of anti-inflammatory drugs treats autoimmune disorders like rheumatoid arthritis and psoriasis as expected, but one study took a surprising turn when researchers found that the same drugs appeared capable of also treating depression.
Cytokines are a category of signaling molecules that mediate and regulate immunity, inflammation and hematopoiesis. Credit: Sino Biological Inc.
“Children with high everyday levels of one of these [inflammatory] markers are at greater risk of developing depression and psychosis in adulthood,” researchers from Cambridge found in a previous study. This is strong evidence for scientific theories that chronic low-grade systemic inflammation can lead to mental illness. The current study, again from the University of Cambridge, digs deeper into the relationship between depression and the immune system, and researchers are making giant leaps toward developing new treatments.

A total of 20 clinical trials implementing anti-cytokine monoclonal antibody treatment and cytokine inhibitor drugs to treat autoimmune disease was the first step toward making a connection to mental health. When Cambridge researchers were looking for any additional beneficial side effects of the new drugs, researchers quickly found an antidepressant effect as compared to control groups who received a placebo rather than anti-cytokine drugs.

“These are not your everyday anti-inflammatory drugs such as ibuprofen,” said study leader Golam Khandaker. Cytokines are chemical messengers utilized by the immune system to recruit effector immune cells to a site of infection in order to mount an effective and efficient immune response. Cytokines populate the blood stream as part of this response, and levels of the protein are significantly higher during an infection than in a state of host health. Cytokine levels can also increase even if there is no pathogen infecting the body; sometimes the immune system mistakenly targets healthy host cells as if they were foreign bacteria, which is why scientists turned to anti-cytokine drugs to treat autoimmune diseases like rheumatoid arthritis and psoriasis.

The antidepressant characteristics seen in the anti-cytokine drugs stemmed from seven of the 20 trials, and results from other clinical trials confirmed this finding. Additionally, results from the study’s meta-analysis of anti-cytokine drugs showed that the improvement in the severity of depression occurred independently of any improvements made in physical illness, like rheumatoid arthritis or psoriasis. This is a promising result especially when considering adapting this drug to treat people with depression but without any autoimmune problems.

The new anti-cytokine drugs provide new hope for individuals with depression that don’t respond to existing antidepressant medication. “About a third of patients who are resistant to antidepressants show evidence of inflammation,” Khandaker said. “The current approach of a ‘one-size-fits-all’ medicine to treat depression is problematic.”

All current FDA-approved antidepressant medications in existence target a particular type of neurotransmitter, but not all cases of depression share similar causation pathways. “It’s becoming increasingly clear to us that inflammation plays a role in depression, at least for some individuals,” Khandaker said. Khandaker and the rest of the team from Cambridge will continue to study the anti-depressant effect of the new drugs, looking for any other possible side effects that may occur.

The present study was recently published in the journal Molecular Psychiatry.
 


Sources: University of Cambridge
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 27, 2020
Cell & Molecular Biology
White Blood Cells Are Essential to the Developing Brain
JUL 27, 2020
White Blood Cells Are Essential to the Developing Brain
The brain is protected by a protective shield called the blood-brain barrier, which only allows certain things to pass t ...
AUG 04, 2020
Microbiology
Why the Brain Parasite You May Carry Isn't a Problem
AUG 04, 2020
Why the Brain Parasite You May Carry Isn't a Problem
Toxoplasma gondii is a parasite transmitted by cats and contaminated meat, and it's thought that over 30 million America ...
AUG 27, 2020
Immunology
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
AUG 27, 2020
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
  Living medicines in the form of stem cell therapies have immense potential for their ability to regenerate and he ...
OCT 12, 2020
Genetics & Genomics
The Malaria Parasite Can Change Host Cell Genetics
OCT 12, 2020
The Malaria Parasite Can Change Host Cell Genetics
Mosquitoes can transmit the malaria-causing Plasmodium parasite to humans. Malaria was estimated to have caused the deat ...
NOV 09, 2020
Microbiology
Fighting COVID-19 with Help From Llamas
NOV 09, 2020
Fighting COVID-19 with Help From Llamas
Camelids, which include llamas, alpacas and camels have immune systems that generate two kinds of antibodies when confro ...
NOV 12, 2020
Health & Medicine
Measles Cases and Deaths Surge Worldwide
NOV 12, 2020
Measles Cases and Deaths Surge Worldwide
Today, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) released a stat ...
Loading Comments...